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Three modal periods of death have been acknowledged by
trauma surgeons. The ﬁrst peak of this pattern occurs during the
ﬁrst few hours after injury. The second peak happens after the ﬁrst
24 h wherein haemorrhagic shock contributes highly to mortality.
The third peak occurs after few days of injury, and the cause of
death during this phase is multiple organ dysfunction syndrome
(MODS) to failure (MOF) [1e5].
Response to trauma on one hand ampliﬁes immune system
activation with its end result being cell-mediated organ destruc-
tion, and on the other hand generates an immunosuppressive
environment. Many clinical studies have shown that within hours
after trauma or heavy bleeding, patient condition may deteriorate
to MODS-MOF [3]. Immune mediators and cellular elements
function in coordination and maintain homeostasis for survival;
cytokines are the main regulators among these molecules. Many
studies have clearly identiﬁed the molecular events occurring
after trauma.* Corresponding author
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creativecommons.org/licenses/by-nc-nd/4.0/).Based on the pathogenesis of complications after trauma at the
cellular and molecular level, a better understanding is beneﬁcial to
verify the degree of severity of immune responses to major trauma
[6e9]. Genetic predisposition is another challenging matter in this
context. With advanced molecular diagnostics, the genetic role in
inﬂammatory responses can be elucidated. Single nucleotide
polymorphisms (SNPs) are proven to play a role in several mor-
bidities. Genetic polymorphisms are distinct biomarkers used to
diagnose and determine poor prognoses after trauma. Some studies
have deﬁned the correlation between genetic polymorphisms in
sepsis and MODS after trauma [6,10,11].
The goal of this study is to examine whether genomic variance
might affect individual phenotype in terms of gene expression and
protein production capacity related to susceptibility to compli-
cations after trauma.
2. Methods
This was a prospective cohort study conducted at 4 academic
trauma centres at Kandou hospital, Universitas Hasanuddin hospital,
Kariadi hospital, and Sanglah general hospital. The study included 54
polytrauma patients with Injury Severity Scores (ISS)  16 during 1
year period. The plasma levels and gene expression levels of the
cytokines interleukin-6 (IL-6) and interleukin-10 (IL-10) were
measured over 5 days after polytrauma. The polymorphisms in IL-6
and IL-10 genes were also examined. The patient outcomes such as
multiple organ dysfunction syndrome (MODS) and survival rate
were observed. MODS evaluation was performed using sequential
organ failure assessment (SOFA) methods.
The severity of trauma (ISS), the plasma level and gene
expression level of IL-6 and IL-10, and the polymorphisms in IL-6
and IL-10 genes were analysed by correlation tests.iates Ltd. This is an open access article under the CC BY-NC-ND license (http://
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We collected 54 eligible participants who had completed
follow-up with average observation time about 16.5 days. A cor-
relation between the plasma levels of IL-6 and IL-10 was observed
in a cuboid curve (see Fig. 1) with R2 value being 0.983 for the
MODS group and 0.990 for the non-MODS group. In patients who
progressed to MODS, elevation of the IL-6 plasma level was fol-
lowed by the IL-10 plasma level. This pattern also occurred in the
non-MODS group.
A correlation between the IL-6 and IL-10 plasma concentrations
was observed as a cuboid curve (see Fig. 2) with the R2 value being
0.979 for surviving patients and 0.983 for patients who did not
survive. In the surviving group, elevation of IL-6 plasma level is
followed by the IL-10 plasma levels; whereas in the non-surviving
group, the IL-10 plasma level increased only if the IL-6 plasma level
<50 pg/mL. If the IL-6 plasma level elevated >50 pg/mL, the con-
centration of IL-10 was decreased.
The gene expression level of IL-6 and IL-10 in each outcome
groupwas diverse (see Table 1). Themean IL-6 expression level was
the highest in outcome group 4 (ISS low and surviving) and the
lowest in outcome group 1 (high ISS and not surviving). The IL-6
gene expression in outcome group 2 (high ISS and surviving) was
signiﬁcantly higher than that in outcome group 1 but not signiﬁ-
cant compared to that in outcome group-3. The IL-6 gene expres-
sion in outcome group 2was not signiﬁcantly different compared to
that in outcome group 3. Comparison of the IL-10 gene expression
levels in these outcome groups showed the same pattern as that of
IL-6 gene expression.
The gene expression level of IL-6 and IL-10 was the highest in
patients who had a relatively low ISS score and had survived (see
Fig. 3) and was the lowest in patients who had a high ISS score andFig. 1. Correlation between IL-6 and IL-10 plasma ledid not survive. The gene expression of IL-10 is higher than that of
IL-6 in every outcome group. The gene expression of IL-6 and IL-10
in patients who had low ISS and had not survived was lower than
that in patients who had high ISS and did not survive.
The next step was to analyse the correlation between host fac-
tors such as sex, age, trauma load (ISS), and poor outcome as the
number of organ system dysfunctioning during MODS, the plasma
levels of IL-6 and IL-10, and the occurrence of cytokine gene poly-
morphisms (see Table 2). In all the polytrauma patients in this
study, we found that the IL-10 gene polymorphism (1082 A/G)
could only be found as the AA genotype and no AG or GG genotypes
were observed. For the IL-6 gene polymorphism (174G/C), we did
not encounter the CC genotype, but the AC genotype was found in
only 1 participant, and the rest were of the GG genotype (not
normally distributed). For the IL-10 gene polymorphism (592-C/A),
the genotype was distributed vastly between two kinds as CC (24
samples) and CA (30 samples), and no instance of AA genotype was
found. Because of the correlation analysis of these factors i.e. age,
sex, ISS, MODS, and plasma level of IL-6 and IL-10, genotype, with
the exception in IL-10 polymorphism (592 C/A) CC and CA
genotype.
4. Discussion
4.1. IL-6 and IL-10 plasma level
Concerning the correlation between IL-6 and IL-10 plasma levels
in patients enduring MODS, elevation of IL-6 plasma levels is fol-
lowed by IL-10 levels; this pattern is also observed in patients who
did not have MODS (see Fig. 1). This result is supported by several
studies reporting that secretion of the proinﬂammatory cytokine
IL-6 induces upregulation of the anti-inﬂammatory cytokine IL-10.vels among patients with and without MODS.
Fig. 2. Correlation between IL-6 and IL-10 plasma levels in the surviving and non-surviving groups.
Table 1
IL-6 and IL-10 gene expression in several outcome groups after polytrauma.
Outcome IL-6 gene mRNA expression IL-10 gene mRNA expression
Min/Max Mean (SD) Min/Max Mean (SD)
1 (n ¼ 3) 7.06/714 7.110 (0.044) 10.06/10.22 10.126 (0.083)
2 (n ¼ 9) 11.36/14.93 13.724 (155) 15.43/19.07 17.616 (1.506)
3 (n ¼ 6) 9.54/12.74 11.145 (1.669) 11.69/15.36 13.479 (1.936)
4 (n ¼ 3) 16.00/16.71 16.241 (0.404) 19.24/20.07 19.661 (0.415)
Outcome group 1 ¼ high ISS and no surviving; 2 ¼ high ISS and surviving; 3 ¼ low
ISS and surviving; 4 ¼ low ISS and surviving.
Fig. 3. Box plot of IL-6 and IL-10 gene expression levels in polytrauma patients.
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has a clear impact on the clinical presentation in trauma patients
[12e14].
In surviving patients, elevation of IL-6 plasma levels is followed
by the elevation of IL-10 plasma levels, however, in non-survivors,
elevation of IL-10 is only encountered if the IL-6 plasma level is less
than 50 pg/mL. If the IL-6 plasma levels exceed 50 pg/mL, the
plasma levels of IL-10 were found to be decreased (see Fig. 2). This
condition does not clarify whether the elevation and depression of
IL-10 plasma levels is associated with complications or poor out-
comes or whether these biomarkers indicate the host struggle for
survival. IL-10 is an important component of the negative feedback
against proinﬂammatory cytokines. IL-10 production depends on
the traumamechanism, and the changes in IL-10 plasma levels may
help restore the inﬂammatory response [1,15e17].
Some cytokines play a double role as pro-inﬂammatory and
anti-inﬂammatory cytokines, but these mediators work in orches-
tration to re-establish homeostasis. An imbalance among these
mediators after being triggered by heavy trauma may result in
morbidity and death. In this study, the threshold of severeinﬂammation is a plasma IL-6 level of 50 pg/mL followed by a
decline in the anti-inﬂammatory response demonstrated by the
reduced IL-10 plasma level. If this threshold is breached, poly-
trauma patients may progress to poor outcomes and eventual
death. The correlation test between IL-6 and IL-10 plasma levels
Table 2
Distribution of age, sex, ISS, number of organ systems dysfunctioning during MODS occurrence, IL-6 and IL-10 plasma levels, and polymorphism location and genotype. IL-10;
592-C/A group was distributed vastly while other polymorphism groups were not normally distributed.
Polymorphism genotype N Age (years) sex (M/F) ISS score MODS IL-6 (pg/mL) IL-10 (pg/mL)
IL-10; 1082-A/G AA 54 16e54
(36.4 ± 14.7)
42/12 16e50
(24.1 ± 7.7)
1e4
(1.8 ± 1.1)
15.5e177,4
(47.30 ± 26.18)
21e340.7
(83.70 ± 47.17
AG 0 e e e e e e
GG 0 e e e e e e
IL-10; 592-C/A CC 24 17e54
(38.1 ± 14.3)
21/3 17e35
(23.3 ± 6.2)
1e4
(2.0 ± 1.1)
16.5e62.2
41.18 ± 9.81
30.4e112.2
73.53 ± 17.32
CA 30 16e54
(35.0 ± 15.2)
21/9 16e50
(24.8 ± 8.7)
1e4
1.7 ± 1.1
15.5e112.2
52.19 ± 33.47
21e340.7
91.84 ± 60.62
AA 0 e e e e e e
IL-6; 174 G/C GG 53 16e54
(36.0 ± 14.6)
41/12 16/41
(23.6 ± 6.8)
1e4
1.1 ± 0.2
15.5/177.4
(46.24 ± 25.23)
21.0e340.7
(81.62 ± 45.04)
GC 1 54.0 1/0 50.0 1 103.4 14.15
CC 0 e e e e e e
Table 3
Cross tabulation between the IL-10 gene polymorphism (592C/A) and MODS
MODS Non-MODS Total
IL10 gene
polymorphism-592C/A
CC N 15 9 24
% MODS 60.% 30% 45%
CA N 10 20 30
% MODS 40% 70% 55%
Total N 25 29 54
% MODS 100.0% 100.0% 100.0%
Next, we further cross tabulated the incidence of MODS and the IL-10 gene poly-
morphism (592C/A) (see Table 3). The c2 test is considered to be qualiﬁed if the
expected value < 20%. This c2 test resulted in c2 ¼ 5.247 with p ¼ 0.022 (p < 0.05)
indicating a signiﬁcant association between IL-10 (592C/A) and MODS occurrence
with an odds ratio of 3.7.
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IL-6 was balanced by its anti-inﬂammatory counterpart until the IL-
6 threshold at 50 pg/mL, followed by a reduction in IL-10 plasma
levels. This heavy immune response may progress to immune
system failure as a defeat of the anti-inﬂammatory side according
to the Bone theory (SIRS > CARS), eventually resulting in death
[1,14].
4.2. IL-6 and IL-10 gene expression levels
Animal studies show that mRNA expression is signiﬁcantly
higher during major trauma. Elevation of IL-10 mRNA expression
might be beneﬁcial to slow down the pro-inﬂammatory response,
facilitate cellular and tissue repair, and attain a balance between the
pro- and anti-inﬂammatory mediators. If during minor trauma, IL-
10 mRNA expression is higher than normal, the host succeeds in
attaining homeostasis after trauma [18e22]. Our study supports
this concept in which elevation of IL-10 is an important buffer
mechanism for the pro-inﬂammatory storm aftermajor trauma and
elevation of IL-6 plasma levels is proportionate with IL-6 gene
expression levels. Brumen et al. (2014) obtained a different result.
Brumen studied 20 multitrauma subjects and used the NISS score
and established a threshold of new injury severity score (NISS) > 41
as a distinctive border to classify minor and major trauma, and an
mRNA expression proﬁle within polymorphonuclear cells showed
that IL-6 plasma level are higher in less severe trauma (NISS < 40).
The result of the Brumen study is in accordance with an animal
study that investigated IL-6 and IL-10 mRNA expression levels in
proportion with the severity of the injury (see Table 1 and Fig. 3).
4.3. IL-6 and IL-10 gene polymorphisms
Cytokine gene polymorphisms associated with inﬂammation
may affect the physiological response and clinical manifestationafter trauma [23e25]. Hidebrand et al. found that the incidence of
polymorphisms is higher in SIRS patients who have the homozy-
gous allele genotype IL-6-174G. Schluter et al. found that patients
suffering from severe sepsis after surgery have better chance of
survival if they have the GG genotype. This study demonstrated
that IL-6 caused a reduction in mortality rate and multiple organ
dysfunction after SIRS. However, all the participants with this result
have the same SNP, IL-6 -174, and did not count trauma as early
predictor factor. IL-6 -174 SNP did not show a signiﬁcant difference.
A study of critically ill patients showed an association between
lessening of the IL-10 polymorphism promoter at the allele position
(1082 to819, and592) and mortality risk. Several studies have
demonstrated the functional implication of IL-10 polymorphisms,
and its plasma levels during major trauma or sepsis have different
results [6]. The highest level of IL-10 is found as the GCC/GCC
haplotype. Patients with the 597AC genotype had a higher MODS
score and had a 3.3-fold increased risk to develop MODS [26].
Schroder O et al. (2004) also found that patients with the 597AC
genotype have a 3.3 higher risk of enduring multi-organ dysfunc-
tion. Huebinger et al. (2006) found that the 592A allele IL-10
promoter seemed to decrease the risk of death after burn injury.
This study only included the 592 and 1082 alleles and only
the 592A allele that has a signiﬁcant association with MODS, and
the IL 10e592C/A SNP have an odds ratio of 3.7 (see Table 3).
Immune response is a kind of communication and interaction
that may be upregulated or downregulated continuously to main-
tain balance. When this immune response is halted, immune cells
are considered to be in a “paralysis-tired-rest” state and produce no
response. Unresponsive cells may result from the failure to respond
under the upregulation or downregulation stimuli. Moore
explained the biphasic theory that SIRS > CARS may rapidly lead to
MODS and MOF, and SIRS < CARS will lead to MARS and create
immune paralysis and eventually also causeMODS andMOF slowly.
We did not observe an absolute balance in the immune response
because the immune system is always under stimulation and
buffering. We did not ﬁnd any signiﬁcance of both IL-6 and IL-10
genetic factors in disease outcome. Because long exposure is
needed to change the genetic sequence while in trauma, exposure
occurs in a short time and so, the exact correlation between gene
polymorphisms and plasma level patterns cannot be observed.
Under trauma conditions, mRNA expression levels are the main
countable factors.References
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